Evgueni Borisovich Frolov

Title: Evgueni Borisovich Frolov: Innovator in Pharmaceutical Chemistry

Introduction

Evgueni Borisovich Frolov is a notable inventor based in San Diego, California, recognized for his contributions to the field of pharmaceutical chemistry. He holds a patent that focuses on novel compounds targeting serotonin receptors, which have the potential to offer therapeutic benefits in regulating cellular calcium ion homeostasis.

Latest Patents

Frolov's patent, titled "Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for the production and use thereof," presents innovative antagonists of serotonin 5-HT receptors. These compounds are specifically designed to manage the homeostasis of calcium ions in cells. The patent details a general formula wherein the compounds include various substituents, such as amino groups and aromatic heterocycles, which may enhance their pharmacological efficacy.

Career Highlights

Evgueni Frolov is affiliated with Alla Chem, LLC, a company dedicated to advancing pharmaceutical innovations. His expertise and research have led to significant breakthroughs in drug development, emphasizing the importance of serotonin receptor antagonism in medical treatments.

Collaborations

Frolov collaborates with fellow researchers Andrey Alexandrovich Ivashchenko and Alexandre Vasilievich Ivachtchenko. Together, they contribute to the exploration of novel compounds and methods that enhance the understanding of pharmacological interactions and therapeutic uses.

Conclusion

Evgueni Borisovich Frolov stands out as a key figure in the realm of pharmaceutical innovation. His patent addresses crucial aspects of drug design and development, paving the way for future research that could significantly impact medical therapies. Through his work, Frolov continues to contribute to advancements that may benefit numerous patients in need of effective treatments.